Evaluation of utility of pharmacokinetic studies in phase I trials of two oncology drugs

Por Wu, Kehua, House, Larry, Ramírez, Jacqueline, Seminerio, Michael J., Ratain, Mark J.
Publicado em 2013

Sigma receptor antagonists attenuate acute methamphetamine-induced hyperthermia by a mechanism independent of IL-1β mRNA expression in the hypothalamus

Por Seminerio, Michael J., Robson, Matthew J., McCurdy, Christopher R., Matsumoto, Rae R.
Publicado em 2012

The effect of the pyridyl nitrogen position in pyridylpiperazine sigma ligands

Por Stavitskaya, Lidiya, Seminerio, Michael J., Matthews-Tsourounis, Marilyn M., Matsumoto, Rae R., Coop, Andrew
Publicado em 2010

Sigma (σ) Receptor Ligand, AC927 (N-Phenethylpiperidine Oxalate), Attenuates Methamphetamine-Induced Hyperthermia and Serotonin Damage in Mice

Por Seminerio, Michael J., Kaushal, Nidhi, Shaikh, Jamaluddin, Huber, Jason D., Coop, Andrew, Matsumoto, Rae R.
Publicado em 2010

Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo

Por Kaushal, Nidhi, Seminerio, Michael J., Robson, Matthew J., McCurdy, Christopher R., Matsumoto, Rae R.
Publicado em 2012

The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study

Por Silberstein, Stephen D., Cohen, Joshua M., Seminerio, Michael J., Yang, Ronghua, Ashina, Sait, Katsarava, Zaza
Publicado no J Headache Pain (2020)

In Vitro Evaluation of Guanidine Analogs as Sigma Receptor Ligands for Potential Anti-Stroke Therapeutics

Por Behensky, Adam A., Cortes-Salva, Michelle, Seminerio, Michael J., Matsumoto, Rae R., Antilla, Jon C., Cuevas, Javier
Publicado em 2013

Methamphetamine-induced toxicity: an updated review on issues related to hyperthermia

Por Matsumoto, Rae R., Seminerio, Michael J., Turner, Ryan C., Robson, Matthew J., Nguyen, Linda, Miller, Diane B., O’Callaghan, James P.
Publicado no Pharmacol Ther (2014)

No “Wearing‐Off Effect” Seen in Quarterly or Monthly Dosing of Fremanezumab: Subanalysis of a Randomized Long‐Term Study

Por Blumenfeld, Andrew M., Stevanovic, Darko M., Ortega, Mario, Cohen, Joshua M., Seminerio, Michael J., Yang, Ronghua, Jiang, Bo, Tepper, Stewart J.
Publicado no Headache (2020)

Synthesis and pharmacological evaluation of indole-based sigma receptor ligands

Por Mésangeau, Christophe, Amata, Emanuele, Alsharif, Walid, Seminerio, Michael J., Robson, Matthew J., Matsumoto, Rae R., Poupaert, Jacques H., McCurdy, Christopher R.
Publicado em 2011

CM156, a high affinity sigma ligand, attenuates the stimulant and neurotoxic effects of methamphetamine in mice

Por Kaushal, Nidhi, Seminerio, Michael J., Shaikh, Jamaluddin, Medina, Mark A., Mesangeau, Christophe, Wilson, Lisa L., McCurdy, Christopher R., Matsumoto, Rae R.
Publicado em 2011

Reversion From Chronic Migraine to Episodic Migraine in Patients Treated With Fremanezumab: Post Hoc Analysis From HALO CM Study

Por Lipton, Richard B., Cohen, Joshua M., Bibeau, Kristen, Galic, Maja, Seminerio, Michael J., Ramirez Campos, Verena, Halker Singh, Rashmi B., Ailani, Jessica
Publicado no Headache (2020)

Immunogenicity of biologic therapies for migraine: a review of current evidence

Por Cohen, Joshua M., Ning, Xiaoping, Kessler, Yoel, Rasamoelisolo, Michele, Campos, Verena Ramirez, Seminerio, Michael J., Krasenbaum, Lynda J., Shen, Honglue, Stratton, Jennifer
Publicado no J Headache Pain (2021)

Synthesis and Pharmacological Characterization of a Novel Sigma Receptor Ligand with Improved Metabolic Stability and Antagonistic Effects Against Methamphetamine

Por Seminerio, Michael J., Robson, Matthew J., Abdelazeem, Ahmed H., Mesangeau, Christophe, Jamalapuram, Seshulatha, Avery, Bonnie A., McCurdy, Christopher R., Matsumoto, Rae R.
Publicado em 2011